Shukra Medtech Ltd. (SHUKRAPHAR.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-87.5%

₹9.99

vs ₹79.79 price

Levered DCF

₹3.27

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	60.68×	97.36×	1.89×	0.18×	1.26×	37.35×	5.08×	1.27×
P/B	14.9×	14.84×	0.61×	0.03×	0.06×	0.04×	0.01×	0.04×
P/S	23.6×	28.61×	0.47×	0.01×	0.05×	0.06×	0.02×	0.1×
EV / EBITDA	40.04×	54.58×	1.27×	0.29×	1.36×	6.21×	5.26×	4.08×
Gross margin	53.6%	75.1%	40.3%	22.8%	48.7%	75.3%	74.7%	82.5%
Operating margin	44.6%	29.8%	23.3%	7.9%	6.0%	2.5%	0.5%	42.9%
Net margin	38.9%	29.4%	24.9%	7.5%	3.7%	1.7%	0.3%	8.2%
Current ratio	3.6×	3.79×	3.97×	1.25×	1.28×	2.28×	2.07×	2.77×
Debt / equity	0.02×	0.07×	0.05×	0.2×	0.21×	0.63×	0.52×	0.42×
Interest coverage	23.14×	16.35×	62.81×	16.46×	4.31×	8.4×	29.6×	3,903.73×
Dividend yield	0.0%	0.5%	0.2%	9.3%	0.0%	0.0%	10.7%	13.7%
Payout ratio	2.0%	45.7%	0.4%	1.7%	0.0%	0.0%	55.0%	16.9%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	24.6%	15.2%	32.2%	17.4%	4.6%	1.2%	0.2%	3.0%
Return on invested capital	20.2%	9.9%	25.2%	13.6%	4.0%	1.0%	0.0%	6.3%
Return on assets	18.8%	11.0%	23.8%	5.9%	2.1%	0.5%	0.1%	1.6%
Free cash flow yield	-0.8%	0.6%	-19.9%	-167.9%	680.7%	-179.9%	-1070.9%	-382.7%
Earnings yield	1.6%	1.0%	52.9%	560.0%	79.4%	27.0%	19.5%	80.7%
Enterprise value	₹13.3B	₹9.2B	₹282M	₹19M	₹40.3M	₹99.6M	₹81.1M	₹67.3M
Net debt / EBITDA	-0.12×	-0.47×	-0.31×	0.17×	1.04×	5.77×	5.15×	3.73×
Cash conversion cycle (days)	215	246	80	-55	-29	-163	-327	-450